Tsubota Laboratory Incorporated
Tokyo Stock ExchangeTotal Valuation
Tsubota Laboratory Incorporated carries a market capitalization of 6.29B, placing it among publicly traded companies globally. Its enterprise value stands at 9.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.29B |
| Enterprise Value | 9.87B |
Share Statistics
Tsubota Laboratory Incorporated currently has 25.58M shares outstanding.
| Shares Outstanding | 25.58M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 17.83, and the price-to-book ratio stands at 18.24.
| PE Ratio | N/A |
| PS Ratio | 17.83 |
| PB Ratio | 18.24 |
| P/TBV Ratio | 7.92 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 15.82 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 10,006.05 |
Financial Position
Tsubota Laboratory Incorporated maintains a current ratio of 2.96, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.27, indicating elevated leverage, while an interest coverage ratio of -365.72 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.96 |
| Quick Ratio | 1.86 |
| Debt / Equity | 7.27 |
| Debt / EBITDA | -0.43 |
| Interest Coverage | -365.72 |
Financial Efficiency
| Return on Equity (ROE) | -45.76 |
| Return on Assets (ROA) | -15.34 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -63.99 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.60 |
Taxes
Over the trailing twelve months, Tsubota Laboratory Incorporated has paid 115.18M in income taxes, reflecting an effective tax rate of 0.08.
| Income Tax | 115.18M |
| Effective Tax Rate | 0.08 |
Stock Price Statistics
Tsubota Laboratory Incorporated's stock has declined approximately -36.45833% over the past 52 weeks. The 50-day moving average sits at 252.02, while the 200-day moving average is 311.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.45833% |
| 50-Day Moving Average | 252.02 |
| 200-Day Moving Average | 311.30 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tsubota Laboratory Incorporated generated 624.22M in revenue and converted that into -347.92M in net income, yielding earnings per share of -13.60. EBITDA reached -241.37M, while operating income came in at -241.37M.
| Revenue | 624.22M |
| Gross Profit | 99.10M |
| Operating Income | -241.37M |
| Pretax Income | -232.74M |
| Net Income | -347.92M |
| EBITDA | -241.37M |
| EBIT | -241.37M |
| Earnings Per Share (EPS) | -13.60 |
Balance Sheet
Tsubota Laboratory Incorporated holds 1.36B in cash and equivalents against 102.62M in total debt, resulting in a net debt position of -1.26B. Total book value stands at 610.02M, with working capital of 1.44B providing operational flexibility.
| Cash & Cash Equivalents | 1.36B |
| Total Debt | 102.62M |
| Net Debt | -1.26B |
| Equity (Book Value) | 610.02M |
| Book Value Per Share | 23.85 |
| Working Capital | 1.44B |
Margins
Tsubota Laboratory Incorporated operates with a gross margin of 15.88, reflecting its pricing power and cost economics. The operating margin of -38.67 and net profit margin of -55.74 provide insight into operational efficiency.
| Gross Margin | 15.88 |
| Operating Margin | -38.67 |
| Pretax Margin | -37.29 |
| Profit Margin | -55.74 |
| EBITDA Margin | -38.67 |
Scores
Tsubota Laboratory Incorporated posts an Altman Z-Score of 8.79, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.79 |